Literature DB >> 10369479

Inhibition of HERG channels stably expressed in a mammalian cell line by the antianginal agent perhexiline maleate.

B D Walker1, S M Valenzuela, C B Singleton, H Tie, J A Bursill, K R Wyse, M R Qiu, S N Breit, T J Campbell.   

Abstract

Perhexiline has been used as an anti-anginal agent for over 25 years, and is known to cause QT prolongation and torsades de pointes. We hypothesized that the cellular basis for these effects was blockade of I(Kr). A stable transfection of HERG into a CHO-K1 cell line produced a delayed rectifier, potassium channel with similar properties to those reported for transient expression in Xenopus oocytes. Perhexiline caused voltage- and frequency-dependent block of HERG (IC50 7.8 microM). The rate of inactivation was increased and there was a 10 mV hyperpolarizing shift in the voltage-dependence of steady-state inactivation, suggestive of binding to the inactivated state. In conclusion, perhexiline potently inhibits transfected HERG channels and this is the probable mechanism for QT prolongation and torsades de pointes. Channel blockade shows greatest affinity for the inactivated state.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369479      PMCID: PMC1565989          DOI: 10.1038/sj.bjp.0702502

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Novel mechanism of HERG current suppression in LQT2: shift in voltage dependence of HERG inactivation.

Authors:  T Nakajima; T Furukawa; T Tanaka; Y Katayama; R Nagai; Y Nakamura; M Hiraoka
Journal:  Circ Res       Date:  1998-08-24       Impact factor: 17.367

2.  Molecular determinants of dofetilide block of HERG K+ channels.

Authors:  E Ficker; W Jarolimek; J Kiehn; A Baumann; A M Brown
Journal:  Circ Res       Date:  1998-02-23       Impact factor: 17.367

3.  Proceedings: Evaluation of anti-arrhythmic efficacy of perhexiline maleate in ambulatory patients by Holter monitoring.

Authors:  F T Drake; O Haring; D H Singer; G Dirnberger
Journal:  Postgrad Med J       Date:  1973-04       Impact factor: 2.401

4.  Proceedings: Effects of perhexiline on the electrophysiologic activity of mammalian heart.

Authors:  R E Ten Eick; D H Singer
Journal:  Postgrad Med J       Date:  1973-04       Impact factor: 2.401

5.  Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.

Authors:  S Mohammad; Z Zhou; Q Gong; C T January
Journal:  Am J Physiol       Date:  1997-11

6.  Supression of ventricular extrasystoles by perhexiline.

Authors:  T G Pickering; L Goulding
Journal:  Br Heart J       Date:  1978-08

7.  A mutation in the pore region of HERG K+ channels expressed in Xenopus oocytes reduces rectification by shifting the voltage dependence of inactivation.

Authors:  A Zou; Q P Xu; M C Sanguinetti
Journal:  J Physiol       Date:  1998-05-15       Impact factor: 5.182

8.  A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.

Authors:  D Rampe; M L Roy; A Dennis; A M Brown
Journal:  FEBS Lett       Date:  1997-11-03       Impact factor: 4.124

9.  Vesnarinone prolongs action potential duration without reverse frequency dependence in rabbit ventricular muscle by blocking the delayed rectifier K+ current.

Authors:  J Toyama; K Kamiya; J Cheng; J K Lee; R Suzuki; I Kodama
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

10.  Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells.

Authors:  W H Barry; J D Horowitz; T W Smith
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

View more
  10 in total

1.  A novel method for patch-clamp automation.

Authors:  D Vasilyev; T Merrill; A Iwanow; J Dunlop; M Bowlby
Journal:  Pflugers Arch       Date:  2006-04-05       Impact factor: 3.657

2.  Predicting the potency of hERG K⁺ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models.

Authors:  Yayu Tan; Yadong Chen; Qidong You; Haopeng Sun; Manhua Li
Journal:  J Mol Model       Date:  2011-06-10       Impact factor: 1.810

3.  Inhibition of HERG potassium channels by the antimalarial agent halofantrine.

Authors:  H Tie; B D Walker; C B Singleton; S M Valenzuela; J A Bursill; K R Wyse; S N Breit; T J Campbell
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

4.  Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states.

Authors:  B D Walker; C B Singleton; J A Bursill; K R Wyse; S M Valenzuela; M R Qiu; S N Breit; T J Campbell
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 5.  Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty.

Authors:  Rashmi R Shah; Peter D Stonier
Journal:  Ther Adv Drug Saf       Date:  2018-06-18

6.  Stereoselective Inhibition of the hERG1 Potassium Channel.

Authors:  Liliana Sintra Grilo; Pierre-Alain Carrupt; Hugues Abriel
Journal:  Front Pharmacol       Date:  2010-11-22       Impact factor: 5.810

7.  Cardiac Arrhythmias and Antiarrhythmic Drugs: An Autophagic Perspective.

Authors:  Joanne J A van Bavel; Marc A Vos; Marcel A G van der Heyden
Journal:  Front Physiol       Date:  2018-02-23       Impact factor: 4.566

Review 8.  Changes in Myocardial Metabolism Preceding Sudden Cardiac Death.

Authors:  J Snyder; R Zhai; A I Lackey; P Y Sato
Journal:  Front Physiol       Date:  2020-06-16       Impact factor: 4.566

Review 9.  Modeling cardiac complexity: Advancements in myocardial models and analytical techniques for physiological investigation and therapeutic development in vitro.

Authors:  Neal I Callaghan; Sina Hadipour-Lakmehsari; Shin-Haw Lee; Anthony O Gramolini; Craig A Simmons
Journal:  APL Bioeng       Date:  2019-02-05

10.  Functional analysis of molecular and pharmacological modulators of mitochondrial fatty acid oxidation.

Authors:  Yibao Ma; Wei Wang; Teja Devarakonda; Huiping Zhou; Xiang-Yang Wang; Fadi N Salloum; Sarah Spiegel; Xianjun Fang
Journal:  Sci Rep       Date:  2020-01-29       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.